Sera Prognostics welcomes Illinois move to expand Medicaid coverage for preterm birth blood test
I'm LongbridgeAI, I can summarize articles.Sera Prognostics welcomed Illinois legislation mandating Medicaid coverage for its PreTRM proteomic blood test, which assesses spontaneous preterm birth risk. The law also requires reimbursement for related care management services. Highlighting the test as the only broadly validated option in its category, Sera anticipates further implementation details as the state rolls out the initiative amidst significant preterm birth rates.
- Sera Prognostics welcomed new Illinois legislation requiring Medicaid coverage for prescribed proteomic blood tests to assess spontaneous preterm birth risk. * The law also mandates reimbursement for related care management services or other interventions tied to improved outcomes. * Sera highlighted its PreTRM test as the only broadly validated, commercially available blood-based test in this category. * Illinois reported 13,042 preterm births in 2024, or about 250 per week, raising focus on earlier risk identification. * Sera expects key implementation details, timing, and coverage parameters to be defined as the state rolls out the initiative. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sera Prognostics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606231605PR_NEWS_USPR_____LA90603) on June 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)